In a recent meta-analysis of 48 studies on 29,776 patients treated with anti-TNF medications for IBD, the authors demonstrated that the incidence of dermatological events in patients with IBD on anti-TNF medications was high [15]. This evidence concerns the gene TNF and inflammatory bowel disease.